Recent Posts
- Change is Coming to Australia! Patent Term Extension to No Longer be Available for Formulations
- James Peel Joins Schlich
- Seagen vs Daiichi Sankyo: A Warning Shot for Broad Biologic Platform Patents in the US
- UPC Takes EPO Approach when Assessing Patentability of Broad Antibody Claims in Amgen v Sanofi
- Claim Interpretation and Other Lessons from Otec v. Steros at the UPC Court of Appeal
Recent Comments